Salarius Historical Balance Sheet

SLRX Stock

USD 1.52 0.15 10.95%

Trend analysis of Salarius Pharmaceuticals balance sheet accounts such as Property Plant And Equipment Net of 6.7 K, Accounts Payable of 572.7 K, Cash of 5.6 M or Non Current Assets Total of 63.5 K provides information on Salarius Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Salarius Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Salarius Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Salarius Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Salarius Pharmaceuticals is a good buy for the upcoming year.

Salarius Pharmaceuticals Inventory

(1.38 Million)

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Salarius Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Salarius Stock please use our How to Invest in Salarius Pharmaceuticals guide.

About Salarius Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Salarius Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Salarius Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Salarius Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Salarius currently owns. An asset can also be divided into two categories, current and non-current.

Salarius Pharmaceuticals Balance Sheet Chart

At this time, Salarius Pharmaceuticals' Short Term Debt is fairly stable compared to the past year.

Total Assets Other Current Liab Total Current Liabilities Property Plant And Equipment Net

Add Fundamental

Total Assets

Total assets refers to the total amount of Salarius Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Salarius Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Salarius Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Salarius Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from Salarius Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Salarius Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Salarius Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Salarius Stock please use our How to Invest in Salarius Pharmaceuticals guide.At this time, Salarius Pharmaceuticals' Short Term Debt is fairly stable compared to the past year.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	567.8K	1.4M	406.7K	532.5K
Total Assets	40.8M	14.7M	6.6M	6.3M

Other Current Liab Total Assets

Salarius Pharmaceuticals balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Net Tangible Assets	Other Assets	Retained Earnings Total Equity	Common Stock Shares Outstanding	Capital Surpluse	Deferred Long Term Liab
Total Assets		0.36	0.13	0.74	0.75	-0.87	0.24	0.39	0.87	-0.07	-0.36	0.98	-0.14	0.09	0.21	-0.13	0.11	0.75	0.99	0.26	0.46	0.11	-0.35	-0.51	0.52	0.43
Other Current Liab	0.36		0.01	0.43	-0.01	-0.47	0.04	-0.02	0.47	-0.15	-0.61	0.37	0.17	-0.18	0.16	-0.16	-0.19	-0.01	0.38	-0.02	0.25	0.03	-0.28	0.07	-0.06	0.09
Total Current Liabilities	0.13	0.01		0.51	0.47	0.22	-0.43	0.91	-0.22	0.07	-0.42	0.1	0.45	-0.64	0.72	0.57	-0.59	0.48	0.12	0.26	-0.61	-0.09	0.64	0.03	-0.16	0.09
Total Stockholder Equity	0.74	0.43	0.51		0.71	-0.41	-0.25	0.58	0.41	0.1	-0.7	0.69	0.45	-0.61	0.69	0.39	-0.58	0.72	0.71	0.56	-0.2	0.2	0.25	-0.1	0.06	0.16
Property Plant And Equipment Net	0.75	-0.01	0.47	0.71		-0.43	-0.26	0.71	0.43	-0.32	-0.45	0.78	0.02	-0.18	0.28	0.39	-0.14	1.0	0.78	0.16	-0.04	-0.23	0.13	-0.45	0.58	0.27
Net Debt	-0.87	-0.47	0.22	-0.41	-0.43		-0.43	-0.07	-1.0	0.18	0.16	-0.89	0.38	-0.44	0.16	0.44	-0.45	-0.42	-0.88	-0.05	-0.8	-0.14	0.72	0.49	-0.6	-0.4
Retained Earnings	0.24	0.04	-0.43	-0.25	-0.26	-0.43		-0.41	0.44	0.4	0.41	0.17	-0.62	0.66	-0.16	-0.94	0.65	-0.28	0.17	-0.23	0.72	0.12	-0.68	-0.3	-0.05	0.31
Accounts Payable	0.39	-0.02	0.91	0.58	0.71	-0.07	-0.41		0.07	-0.08	-0.38	0.37	0.3	-0.44	0.51	0.55	-0.38	0.71	0.39	0.3	-0.4	-0.09	0.48	-0.27	0.23	0.34
Cash	0.87	0.47	-0.22	0.41	0.43	-1.0	0.44	0.07		-0.18	-0.16	0.89	-0.38	0.44	-0.16	-0.45	0.45	0.42	0.88	0.05	0.8	0.14	-0.72	-0.5	0.59	0.41
Non Current Assets Total	-0.07	-0.15	0.07	0.1	-0.32	0.18	0.4	-0.08	-0.18		0.28	-0.24	0.12	-0.22	0.45	-0.19	-0.23	-0.33	-0.23	0.58	-0.2	0.62	0.28	-0.05	-0.55	0.25
Non Currrent Assets Other	-0.36	-0.61	-0.42	-0.7	-0.45	0.16	0.41	-0.38	-0.16	0.28		-0.38	-0.4	0.6	-0.45	-0.34	0.59	-0.46	-0.4	-0.01	0.24	0.39	-0.19	-0.09	0.02	0.16
Cash And Short Term Investments	0.98	0.37	0.1	0.69	0.78	-0.89	0.17	0.37	0.89	-0.24	-0.38		-0.18	0.14	0.11	-0.1	0.17	0.78	1.0	0.15	0.49	0.01	-0.4	-0.49	0.61	0.37
Common Stock Total Equity	-0.14	0.17	0.45	0.45	0.02	0.38	-0.62	0.3	-0.38	0.12	-0.4	-0.18		-0.84	0.57	0.69	-0.84	0.04	-0.16	0.56	-0.71	0.29	0.62	0.6	-0.49	-0.25
Non Current Liabilities Total	0.09	-0.18	-0.64	-0.61	-0.18	-0.44	0.66	-0.44	0.44	-0.22	0.6	0.14	-0.84		-0.78	-0.75	1.0	-0.2	0.12	-0.52	0.85	-0.14	-0.81	-0.43	0.51	0.26
Other Current Assets	0.21	0.16	0.72	0.69	0.28	0.16	-0.16	0.51	-0.16	0.45	-0.45	0.11	0.57	-0.78		0.36	-0.76	0.3	0.14	0.48	-0.56	0.25	0.56	0.32	-0.58	-0.15
Other Stockholder Equity	-0.13	-0.16	0.57	0.39	0.39	0.44	-0.94	0.55	-0.45	-0.19	-0.34	-0.1	0.69	-0.75	0.36		-0.74	0.4	-0.1	0.43	-0.82	0.03	0.82	0.25	-0.02	-0.19
Total Liab	0.11	-0.19	-0.59	-0.58	-0.14	-0.45	0.65	-0.38	0.45	-0.23	0.59	0.17	-0.84	1.0	-0.76	-0.74		-0.16	0.15	-0.52	0.84	-0.15	-0.8	-0.47	0.54	0.29
Property Plant And Equipment Gross	0.75	-0.01	0.48	0.72	1.0	-0.42	-0.28	0.71	0.42	-0.33	-0.46	0.78	0.04	-0.2	0.3	0.4	-0.16		0.78	0.17	-0.05	-0.22	0.14	-0.42	0.56	0.25
Total Current Assets	0.99	0.38	0.12	0.71	0.78	-0.88	0.17	0.39	0.88	-0.23	-0.4	1.0	-0.16	0.12	0.14	-0.1	0.15	0.78		0.16	0.48	0.01	-0.39	-0.49	0.6	0.38
Common Stock	0.26	-0.02	0.26	0.56	0.16	-0.05	-0.23	0.3	0.05	0.58	-0.01	0.15	0.56	-0.52	0.48	0.43	-0.52	0.17	0.16		-0.36	0.8	0.45	-0.01	-0.14	0.22
Net Tangible Assets	0.46	0.25	-0.61	-0.2	-0.04	-0.8	0.72	-0.4	0.8	-0.2	0.24	0.49	-0.71	0.85	-0.56	-0.82	0.84	-0.05	0.48	-0.36		-0.02	-0.97	-0.41	0.5	0.26
Other Assets	0.11	0.03	-0.09	0.2	-0.23	-0.14	0.12	-0.09	0.14	0.62	0.39	0.01	0.29	-0.14	0.25	0.03	-0.15	-0.22	0.01	0.8	-0.02		0.09	0.13	-0.25	0.18
Retained Earnings Total Equity	-0.35	-0.28	0.64	0.25	0.13	0.72	-0.68	0.48	-0.72	0.28	-0.19	-0.4	0.62	-0.81	0.56	0.82	-0.8	0.14	-0.39	0.45	-0.97	0.09		0.21	-0.38	-0.07
Common Stock Shares Outstanding	-0.51	0.07	0.03	-0.1	-0.45	0.49	-0.3	-0.27	-0.5	-0.05	-0.09	-0.49	0.6	-0.43	0.32	0.25	-0.47	-0.42	-0.49	-0.01	-0.41	0.13	0.21		-0.73	-0.81
Capital Surpluse	0.52	-0.06	-0.16	0.06	0.58	-0.6	-0.05	0.23	0.59	-0.55	0.02	0.61	-0.49	0.51	-0.58	-0.02	0.54	0.56	0.6	-0.14	0.5	-0.25	-0.38	-0.73		0.45
Deferred Long Term Liab	0.43	0.09	0.09	0.16	0.27	-0.4	0.31	0.34	0.41	0.25	0.16	0.37	-0.25	0.26	-0.15	-0.19	0.29	0.25	0.38	0.22	0.26	0.18	-0.07	-0.81	0.45

Click cells to compare fundamentals

Salarius Pharmaceuticals Account Relationship Matchups

Salarius Pharmaceuticals balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	13.9M	24.9M	40.8M	14.7M	6.6M	6.3M
Other Current Liab	478.5K	442.3K	567.8K	1.4M	406.7K	532.5K
Total Current Liabilities	3.3M	2.8M	2.1M	4.3M	1.3M	2.3M
Total Stockholder Equity	10.6M	22.2M	38.7M	10.4M	5.3M	5.0M
Property Plant And Equipment Net	74K	25.0K	22.6K	7.9K	7.1K	6.7K
Net Debt	(3.2M)	(10.6M)	(29.2M)	(12.1M)	(5.6M)	(5.9M)
Retained Earnings	(12.1M)	(19.4M)	(32.2M)	(63.8M)	(76.3M)	(80.2M)
Accounts Payable	1.8M	1.9M	1.5M	2.9M	602.9K	572.7K
Cash	3.7M	11.1M	29.2M	12.1M	5.9M	5.6M
Non Current Assets Total	9.2M	9.1M	10.7M	130.5K	66.9K	63.5K
Non Currrent Assets Other	308.7K	247.1K	1.8M	130.5K	66.9K	63.5K
Cash And Short Term Investments	3.7M	11.1M	29.2M	12.1M	5.9M	5.6M
Common Stock Total Equity	1.8K	1.8K	451.0	2.4K	2.7K	1.6K
Liabilities And Stockholders Equity	13.9M	24.9M	40.8M	14.7M	6.6M	6.3M
Non Current Liabilities Total	980.9K	919.4K	567.8K	1.4M	406.7K	386.4K
Other Current Assets	955.9K	822.1K	949.2K	803.4K	619.8K	816.3K
Other Stockholder Equity	22.7M	41.6M	70.9M	74.2M	81.6M	82.0M
Total Liab	3.3M	2.8M	2.1M	4.3M	1.3M	1.2M
Property Plant And Equipment Gross	331.0K	74.5K	25.0K	22.6K	20.4K	19.4K
Total Current Assets	4.7M	15.8M	30.2M	14.5M	6.5M	6.2M
Common Stock	451.0	2.4K	4.5K	225.0	393.0	373.35
Net Tangible Assets	1.7M	13.3M	29.9M	10.4M	9.3M	14.2M
Other Assets	0.0	247.1K	1.8M	130.5K	1.0	0.95
Common Stock Shares Outstanding	130.7K	623.1K	1.7M	2.1M	3.3M	3.4M
Capital Surpluse	140.2M	142.2M	22.7M	41.6M	37.4M	35.6M
Property Plant Equipment	37.5K	25.0K	22.6K	7.9K	7.1K	6.7K
Inventory	432K	187K	0.0	(1.6M)	(1.4M)	(1.4M)
Net Invested Capital	11.1M	22.6M	38.7M	10.4M	5.6M	5.3M
Net Working Capital	1.4M	13.0M	28.1M	10.3M	5.2M	5.0M
Capital Stock	451.0	2.4K	4.5K	225.0	393.0	373.35

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Salarius Stock Analysis

When running Salarius Pharmaceuticals' price analysis, check to measure Salarius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Salarius Pharmaceuticals is operating at the current time. Most of Salarius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Salarius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Salarius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Salarius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Salarius Historical Balance Sheet

Salarius Pharmaceuticals Inventory

(1.38 Million)

About Salarius Balance Sheet Analysis

Salarius Pharmaceuticals Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Salarius Pharmaceuticals balance sheet Correlations

Salarius Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Salarius Pharmaceuticals balance sheet Accounts

Also Currently Popular

Additional Tools for Salarius Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 1.0	Non Current Liabilities Total
Total Current Assets	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.98	Total Assets
Accounts Payable	+ 0.91	Total Current Liabilities

Cash	- 1.0	Net Debt
Retained Earnings Total Equity	- 0.97	Net Tangible Assets
Other Stockholder Equity	- 0.94	Retained Earnings
Cash And Short Term Investments	- 0.89	Net Debt
Total Current Assets	- 0.88	Net Debt
Net Debt	- 0.87	Total Assets